Nation's evolving role in global pharma enhanced
- Posted on June 24, 2026
- By The China Daily
- 0 Views
- 1 min read
Nation's evolving role in global pharma enhanced
Samsung Epis Holdings has opened its first biopharmaceutical research and development center in China focused on antibody-drug conjugates, or ADCs, joining a growing list of multinational drugmakers deepening their presence in a country that has become one of the world's most active hubs for cancer drug innovation.
